Corcept Therapeutics ($CORT) Insider Trading & Smart Money Activity

Corcept Therapeutics Incorporated · Biotechnology · Latest filing Oct 15, 2026

Corcept Therapeutics Incorporated ($CORT) has 11 insider trades, 2 13F position changes and 1 analyst rating on file. In the last 12 months on the open market, no insider bought and 7 insiders sold ($11.98M), net -$11.98M.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 7
Net insider $ (12 mo): -$11.98M
Congress trades (12 mo): 0
13F moves on file: 2
Analyst ratings on file: 1

CORT insider buying and selling by quarter

Quarter	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0 / 0	0 / 0
Q2 2026	3 · $5.77M	0 / 0	2 / 0
Q3 2026	1 · $29.84K	0 / 0	0 / 0
Q4 2026	6 · $6.18M	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All CORT insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	Filing	Story
Oct 15, 2026	Insider	James N WilsonDirector	Sell (Open-market sale) 10b5-1	10K sh	$1.15M	-0.94%			SEC	Read
Oct 2, 2026	Insider	Vieira Roberto WandenkolkPresident, Oncology	Sell (Open-market sale) 10b5-1	8.33K sh	$967.45K		+4.3%			—
Oct 2, 2026	Insider	Maduck SeanSee Remarks	Sell (Open-market sale) 10b5-1	24.59K sh	$2.86M		+4.3%			—
Oct 2, 2026	Insider	Lyon Joseph DouglasChief Accounting & Technology Officer	Sell (Open-market sale) 10b5-1	9.19K sh	$1.07M		+4.3%			—
Oct 1, 2026	Insider	Maduck SeanSee Remarks	Sell (Open-market sale) 10b5-1	413 sh	$47.72K		+4.0%			—
Oct 1, 2026	Insider	Lyon Joseph DouglasChief Accounting & Technology Officer	Sell (Open-market sale) 10b5-1	810 sh	$93.47K		+4.0%			—
Sep 18, 2026	Analyst	HC Wainwright	Reiterates to Buy		PT $165		+5.3%			—
Sep 16, 2026	Insider	Vieira Roberto WandenkolkPresident, Oncology	Sell (Open-market sale) 10b5-1	296 sh	$29.84K		+1.0%	-1.5%		—
Jun 17, 2026	Insider	David Mahoney	Sell (Open-market sale)	20K sh	$1.69M		-0.2%	+10.7%		—
Jun 16, 2026	Insider	James Wilson	Sell (Open-market sale) 10b5-1	10K sh	$832.02K		-4.6%	+7.2%		—
Jun 15, 2026	Insider	Atabak MokariChief Financial Officer	Sell (Open-market sale) 10b5-1	40K sh	$3.25M		-4.1%	+7.8%		—
Jun 15, 2026	Insider	Atabak MokariChief Financial Officer	Buy (Option exercise)	40K sh	$770.40K		-4.1%	+7.8%		—
May 15, 2026	13F	Caption Management	New	+260K sh	$21.56M		+6.8%	+47.5%		—
May 15, 2026	13F	Caption Management	New	+260K sh	$22.61M		+6.8%	+47.5%		Read

1W / 1M / 6M = how CORT moved from the trade or filing date.

Insider trading in CORT: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
James N Wilson	Director	1	-$1.15M	1.05M	Oct 15, 2026
Vieira Roberto Wandenkolk	President, Oncology	2	-$997.29K		Oct 2, 2026
Maduck Sean	See Remarks	2	-$2.91M		Oct 2, 2026
Lyon Joseph Douglas	Chief Accounting & Technology Officer	2	-$1.16M		Oct 2, 2026
David Mahoney		1	-$1.69M		Jun 17, 2026
James Wilson		1	-$832.02K		Jun 16, 2026
Atabak Mokari	Chief Financial Officer	2	-$3.25M		Jun 15, 2026

Institutions moving CORT (13F)

Caption Management2

Analyst ratings on CORT

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Sep 18, 2026	HC Wainwright	Reiterates	Buy	$165	+5.3%			—

Frequently asked questions

Are CORT insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 7 insiders made 10 open-market sales worth $11.98M, a net -$11.98M.

What is the latest insider trade in CORT?

James N Wilson, Director filed a sell (open-market sale) of 10K sh worth $1.15M on Oct 15, 2026.

Which institutions changed their CORT positions?

Recent 13F filers moving the stock include Caption Management.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text